Operator: Good afternoon, and welcome to Oncolytics Biotech First Quarter Conference Call. All participants are in a listen-only mode.

the ability to be taken to tumor sites via monocytes and lymphocytes, and that it doesn't create anti-agent antibodies, allowing T cells to reach the tumor for long-lasting responses, all without ...

Two research articles published in Nature Genetics shed new light on the cellular complexity of glioblastoma, the most ...

A series of preclinical studies show that a new compound, SHP1705, targets circadian clock proteins hijacked by glioblastoma ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

Ovarian cysts, which are small fluid-filled sacs that develop in or on the ovaries, are very common and are usually harmless.

Tumor Necrosis Factor-α (TNFα) has been reported to be elevated in lung diseases. Cells were stimulated basolaterally with TNFα at specified concentrations for 72 hours, and a dose-dependent ...

Activated T cells undergo metabolic reprogramming to optimize effector functions, but the underlying mechanisms remain elusive. Here the authors show, using knockout and tumor mouse models ...

Stem-cell research is the area of research that studies the properties of stem cells and their potential use in medicine. As stem cells are the source of all tissues, understanding their ...

Here, they are captured by the APCs, which then cause apoptosis among the antigen-specific T cells or differentiation in the suppressor T cells, which produce suppressive TGF-b. A breach in the ...

The US regulator has approved Aucatzyl (obecabtagene autoleucel or obe-cel) for the treatment of adults with relapsed or refractory B-cell precursor ALL based on the results of the phase 2 FELIX ...